Maraviroc exposure is influenced by exogenous thyrotoxicosis

AIDS. 2021 Mar 15;35(4):701-703. doi: 10.1097/QAD.0000000000002754.

David Metsu^{1

2}, Christian Aquilina³, Pierre Delobel^{4

5}, Peggy Gandia^{1

2}, Frédérique Savagner^{6

7}, Stéphanie Raymond^{5

8}, Philippe Caron^{7

9}, Guillaume Martin-Blondel^{4

5}

¹ Laboratory of Pharmacokinetics and Toxicology, Purpan Hospital, University Hospital of Toulouse.
² INTHERES UMR1436 INRA-ENVT.
³ Department of Dermatology, Paul Sabatier University and Larrey Hospital.
⁴ Department of Infectious Diseases, University Hospital of Toulouse.
⁵ Inserm U1043 - CNRS UMR 5282, Toulouse-Purpan Pathophysiology Center.
⁶ Biochemistry and Genetic Laboratory, Federative Institute of Biology, CHU Toulouse.
⁷ Team 6, Inserm UMR 1048, Institute of Metabolic and Cardiovascular Diseases (I2MC), CHU Rangueil.
⁸ Department of Virology, CHU Purpan.
⁹ Department of Endocrinology and Metabolic Diseases, Pôle Cardiovascular and Metabolic, Larrey University Hospital, Toulouse, France.

No abstract available

MeSH terms